ENTRY       mmu05012                    Pathway
NAME        Parkinson disease - Mus musculus (mouse)
DESCRIPTION Parkinson disease (PD) is a progressive neurodegenerative movement disorder that results primarily from the death of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNc). Mutations in alpha-synuclein, UCHL1 (a ubiquitin carboxy-terminal hydrolase L1), parkin, DJ1 (a parkin-associated protein involved with oxidative stress), and PINK1 (a putative serine threonine kinase) are known to cause early-onset PD. Mutations or altered expression of these proteins contributes to the damage and subsequent loss of DA neurons through common mechanisms that result in proteasome dysfunction, mitochondrial impairment, and oxidative stress. The demise of DA neurons located in the SNc leads to a drop in the dopaminergic input to the striatum. This results in a reduced activation of the direct pathway and in a disinhibition of the indirect pathway, which is associated with the elevation of adenosine A2A receptor transmission. Such unbalanced activity of the striatal output pathway is at the basis of the motor impairment observed in PD.
CLASS       Human Diseases; Neurodegenerative disease
PATHWAY_MAP mmu05012  Parkinson disease
ORGANISM    Mus musculus (mouse) [GN:mmu]
GENE        11540  Adora2a; adenosine A2a receptor [KO:K04266]
            14680  Gnal; guanine nucleotide binding protein, alpha stimulating, olfactory type [KO:K04633]
            13489  Drd2; dopamine receptor D2 [KO:K04145]
            14677  Gnai1; guanine nucleotide binding protein (G protein), alpha inhibiting 1 [KO:K04630]
            14679  Gnai3; guanine nucleotide binding protein (G protein), alpha inhibiting 3 [KO:K04630]
            14678  Gnai2; guanine nucleotide binding protein (G protein), alpha inhibiting 2 [KO:K04630]
            224129  Adcy5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]
            18747  Prkaca; protein kinase, cAMP dependent, catalytic, alpha [KO:K04345] [EC:2.7.11.11]
            18749  Prkacb; protein kinase, cAMP dependent, catalytic, beta [KO:K04345] [EC:2.7.11.11]
            13488  Drd1; dopamine receptor D1 [KO:K04144]
            22202  Uba1y; ubiquitin-activating enzyme, Chr Y [KO:K03178] [EC:6.2.1.45]
            22201  Uba1; ubiquitin-like modifier activating enzyme 1 [KO:K03178] [EC:6.2.1.45]
            74153  Uba7; ubiquitin-like modifier activating enzyme 7 [KO:K10698] [EC:6.2.1.45]
            22187  Ubb; ubiquitin B [KO:K04551]
            22195  Ube2l3; ubiquitin-conjugating enzyme E2L 3 [KO:K04552] [EC:2.3.2.23]
            100042355  Gm10705; predicted gene 10705 [KO:K04552] [EC:2.3.2.23]
            56791  Ube2l6; ubiquitin-conjugating enzyme E2L 6 [KO:K04553] [EC:2.3.2.23]
            140499  Ube2j2; ubiquitin-conjugating enzyme E2J 2 [KO:K04554] [EC:2.3.2.23]
            56228  Ube2j1; ubiquitin-conjugating enzyme E2J 1 [KO:K10578] [EC:2.3.2.23]
            22213  Ube2g2; ubiquitin-conjugating enzyme E2G 2 [KO:K04555] [EC:2.3.2.23]
            67128  Ube2g1; ubiquitin-conjugating enzyme E2G 1 [KO:K10575] [EC:2.3.2.23]
            50873  Prkn; parkin RBR E3 ubiquitin protein ligase [KO:K04556] [EC:2.3.2.31]
            20617  Snca; synuclein, alpha [KO:K04528]
            14763  Gpr37; G protein-coupled receptor 37 [KO:K04243]
            18951  Sept5; septin 5 [KO:K04557]
            67847  Sncaip; synuclein, alpha interacting protein (synphilin) [KO:K04558]
            22223  Uchl1; ubiquitin carboxy-terminal hydrolase L1 [KO:K05611] [EC:3.4.19.12]
            21823  Th; tyrosine hydroxylase [KO:K00501] [EC:1.14.16.2]
            13162  Slc6a3; solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 [KO:K05036]
            110877  Slc18a1; solute carrier family 18 (vesicular monoamine), member 1 [KO:K08155]
            214084  Slc18a2; solute carrier family 18 (vesicular monoamine), member 2 [KO:K08155]
            17716  ND1; NADH dehydrogenase subunit 1 [KO:K03878] [EC:7.1.1.2]
            17717  ND2; NADH dehydrogenase subunit 2 [KO:K03879] [EC:7.1.1.2]
            17718  ND3; NADH dehydrogenase subunit 3 [KO:K03880] [EC:7.1.1.2]
            17719  ND4; NADH dehydrogenase subunit 4 [KO:K03881] [EC:7.1.1.2]
            17720  ND4L; NADH dehydrogenase subunit 4L [KO:K03882] [EC:7.1.1.2]
            17721  ND5; NADH dehydrogenase subunit 5 [KO:K03883] [EC:7.1.1.2]
            17722  ND6; NADH dehydrogenase subunit 6 [KO:K03884] [EC:7.1.1.2]
            17995  Ndufv1; NADH:ubiquinone oxidoreductase core subunit V1 [KO:K03942] [EC:1.6.99.3 7.1.1.2]
            72900  Ndufv2; NADH:ubiquinone oxidoreductase core subunit V2 [KO:K03943] [EC:1.6.99.3 7.1.1.2]
            78330  Ndufv3; NADH:ubiquinone oxidoreductase core subunit V3 [KO:K03944]
            54405  Ndufa1; NADH:ubiquinone oxidoreductase subunit A1 [KO:K03945]
            17991  Ndufa2; NADH:ubiquinone oxidoreductase subunit A2 [KO:K03946]
            66091  Ndufa3; NADH:ubiquinone oxidoreductase subunit A3 [KO:K03947]
            17992  Ndufa4; Ndufa4, mitochondrial complex associated [KO:K03948]
            407790  Ndufa4l2; Ndufa4, mitochondrial complex associated like 2 [KO:K03948]
            68202  Ndufa5; NADH:ubiquinone oxidoreductase subunit A5 [KO:K03949]
            67130  Ndufa6; NADH:ubiquinone oxidoreductase subunit A6 [KO:K03950]
            66416  Ndufa7; NADH:ubiquinone oxidoreductase subunit A7 [KO:K03951]
            68375  Ndufa8; NADH:ubiquinone oxidoreductase subunit A8 [KO:K03952]
            66108  Ndufa9; NADH:ubiquinone oxidoreductase subunit A9 [KO:K03953]
            67273  Ndufa10; NADH:ubiquinone oxidoreductase subunit A10 [KO:K03954]
            70316  Ndufab1; NADH:ubiquinone oxidoreductase subunit AB1 [KO:K03955]
            239760  Ndufa11b; NADH:ubiquinone oxidoreductase subunit A11B [KO:K03956]
            69875  Ndufa11; NADH:ubiquinone oxidoreductase subunit A11 [KO:K03956]
            66414  Ndufa12; NADH:ubiquinone oxidoreductase subunit A12 [KO:K11352]
            67184  Ndufa13; NADH:ubiquinone oxidoreductase subunit A13 [KO:K11353]
            68198  Ndufb2; NADH:ubiquinone oxidoreductase subunit B2 [KO:K03958]
            66495  Ndufb3; NADH:ubiquinone oxidoreductase subunit B3 [KO:K03959]
            68194  Ndufb4; NADH:ubiquinone oxidoreductase subunit B4 [KO:K03960]
            100042503  Ndufb4b; NADH:ubiquinone oxidoreductase subunit B4B [KO:K03960]
            100041273  Ndufb4c; NADH:ubiquinone oxidoreductase subunit B4C [KO:K03960]
            66046  Ndufb5; NADH:ubiquinone oxidoreductase subunit B5 [KO:K03961]
            230075  Ndufb6; NADH:ubiquinone oxidoreductase subunit B6 [KO:K03962]
            66916  Ndufb7; NADH:ubiquinone oxidoreductase subunit B7 [KO:K03963]
            67264  Ndufb8; NADH:ubiquinone oxidoreductase subunit B8 [KO:K03964]
            66218  Ndufb9; NADH:ubiquinone oxidoreductase subunit B9 [KO:K03965]
            68342  Ndufb10; NADH:ubiquinone oxidoreductase subunit B10 [KO:K03966]
            104130  Ndufb11; NADH:ubiquinone oxidoreductase subunit B11 [KO:K11351]
            227197  Ndufs1; NADH:ubiquinone oxidoreductase core subunit S1 [KO:K03934] [EC:1.6.99.3 7.1.1.2]
            226646  Ndufs2; NADH:ubiquinone oxidoreductase core subunit S2 [KO:K03935] [EC:1.6.99.3 7.1.1.2]
            68349  Ndufs3; NADH:ubiquinone oxidoreductase core subunit S3 [KO:K03936] [EC:1.6.99.3 7.1.1.2]
            17993  Ndufs4; NADH:ubiquinone oxidoreductase core subunit S4 [KO:K03937]
            595136  Ndufs5; NADH:ubiquinone oxidoreductase core subunit S5 [KO:K03938]
            407785  Ndufs6; NADH:ubiquinone oxidoreductase core subunit S6 [KO:K03939]
            75406  Ndufs7; NADH:ubiquinone oxidoreductase core subunit S7 [KO:K03940] [EC:1.6.99.3 7.1.1.2]
            225887  Ndufs8; NADH:ubiquinone oxidoreductase core subunit S8 [KO:K03941] [EC:1.6.99.3 7.1.1.2]
            66377  Ndufc1; NADH:ubiquinone oxidoreductase subunit C1 [KO:K03967]
            68197  Ndufc2; NADH:ubiquinone oxidoreductase subunit C2 [KO:K03968]
            66945  Sdha; succinate dehydrogenase complex, subunit A, flavoprotein (Fp) [KO:K00234] [EC:1.3.5.1]
            67680  Sdhb; succinate dehydrogenase complex, subunit B, iron sulfur (Ip) [KO:K00235] [EC:1.3.5.1]
            66052  Sdhc; succinate dehydrogenase complex, subunit C, integral membrane protein [KO:K00236]
            66925  Sdhd; succinate dehydrogenase complex, subunit D, integral membrane protein [KO:K00237]
            66694  Uqcrfs1; ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 [KO:K00411] [EC:7.1.1.8]
            17711  CYTB; cytochrome b [KO:K00412]
            66445  Cyc1; cytochrome c-1 [KO:K00413]
            22273  Uqcrc1; ubiquinol-cytochrome c reductase core protein 1 [KO:K00414]
            67003  Uqcrc2; ubiquinol cytochrome c reductase core protein 2 [KO:K00415]
            66576  Uqcrh; ubiquinol-cytochrome c reductase hinge protein [KO:K00416]
            67530  Uqcrb; ubiquinol-cytochrome c reductase binding protein [KO:K00417]
            22272  Uqcrq; ubiquinol-cytochrome c reductase, complex III subunit VII [KO:K00418]
            66152  Uqcr10; ubiquinol-cytochrome c reductase, complex III subunit X [KO:K00419]
            66594  Uqcr11; ubiquinol-cytochrome c reductase, complex III subunit XI [KO:K00420]
            17710  COX3; cytochrome c oxidase subunit III [KO:K02262]
            17708  COX1; cytochrome c oxidase subunit I [KO:K02256] [EC:1.9.3.1]
            17709  COX2; cytochrome c oxidase subunit II [KO:K02261]
            12857  Cox4i1; cytochrome c oxidase subunit 4I1 [KO:K02263]
            84682  Cox4i2; cytochrome c oxidase subunit 4I2 [KO:K02263]
            12858  Cox5a; cytochrome c oxidase subunit 5A [KO:K02264]
            12859  Cox5b; cytochrome c oxidase subunit 5B [KO:K02265]
            12861  Cox6a1; cytochrome c oxidase subunit 6A1 [KO:K02266]
            12862  Cox6a2; cytochrome c oxidase subunit 6A2 [KO:K02266]
            110323  Cox6b1; cytochrome c oxidase, subunit 6B1 [KO:K02267]
            333182  Cox6b2; cytochrome c oxidase subunit 6B2 [KO:K02267]
            12864  Cox6c; cytochrome c oxidase subunit 6C [KO:K02268]
            12866  Cox7a2; cytochrome c oxidase subunit 7A2 [KO:K02270]
            12865  Cox7a1; cytochrome c oxidase subunit 7A1 [KO:K02270]
            20463  Cox7a2l; cytochrome c oxidase subunit 7A2 like [KO:K02270]
            66142  Cox7b; cytochrome c oxidase subunit 7B [KO:K02271]
            78174  Cox7b2; cytochrome c oxidase subunit 7B2 [KO:K02271]
            12867  Cox7c; cytochrome c oxidase subunit 7C [KO:K02272]
            12868  Cox8a; cytochrome c oxidase subunit 8A [KO:K02273]
            12869  Cox8b; cytochrome c oxidase subunit 8B [KO:K02273]
            75483  Cox8c; cytochrome c oxidase subunit 8C [KO:K02273]
            11946  Atp5a1; ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1 [KO:K02132]
            11947  Atp5b; ATP synthase, H+ transporting mitochondrial F1 complex, beta subunit [KO:K02133] [EC:7.1.2.2]
            11949  Atp5c1; ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1 [KO:K02136]
            66043  Atp5d; ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit [KO:K02134]
            67126  Atp5e; ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit [KO:K02135]
            17705  ATP6; ATP synthase F0 subunit 6 [KO:K02126]
            11950  Atp5f1; ATP synthase, H+ transporting, mitochondrial F0 complex, subunit B1 [KO:K02127]
            11951  Atp5g1; ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C1 (subunit 9) [KO:K02128]
            67942  Atp5g2; ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C2 (subunit 9) [KO:K02128]
            228033  Atp5g3; ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C3 (subunit 9) [KO:K02128]
            71679  Atp5h; ATP synthase, H+ transporting, mitochondrial F0 complex, subunit D [KO:K02138]
            28080  Atp5o; ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit [KO:K02137]
            11957  Atp5j; ATP synthase, H+ transporting, mitochondrial F0 complex, subunit F [KO:K02131]
            17706  ATP8; ATP synthase F0 subunit 8 [KO:K02125]
            66725  Lrrk2; leucine-rich repeat kinase 2 [KO:K08844] [EC:2.7.11.1]
            68943  Pink1; PTEN induced putative kinase 1 [KO:K05688] [EC:2.7.11.1]
            57320  Park7; Parkinson disease (autosomal recessive, early onset) 7 [KO:K05687] [EC:3.5.1.124]
            64704  Htra2; HtrA serine peptidase 2 [KO:K08669] [EC:3.4.21.108]
            22333  Vdac1; voltage-dependent anion channel 1 [KO:K05862]
            22334  Vdac2; voltage-dependent anion channel 2 [KO:K15040]
            22335  Vdac3; voltage-dependent anion channel 3 [KO:K15041]
            11739  Slc25a4; solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 4 [KO:K05863]
            11740  Slc25a5; solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 5 [KO:K05863]
            73333  Slc25a31; solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 31 [KO:K05863]
            105675  Ppif; peptidylprolyl isomerase F (cyclophilin F) [KO:K09565] [EC:5.2.1.8]
            13063  Cycs; cytochrome c, somatic [KO:K08738]
            13067  Cyct; cytochrome c, testis [KO:K08738]
            11783  Apaf1; apoptotic peptidase activating factor 1 [KO:K02084]
            12371  Casp9; caspase 9 [KO:K04399] [EC:3.4.22.62]
            12367  Casp3; caspase 3 [KO:K02187] [EC:3.4.22.56]
COMPOUND    C00002  ATP
            C00008  ADP
            C00009  Orthophosphate
            C00013  Diphosphate
            C00020  AMP
            C00027  Hydrogen peroxide
            C00082  L-Tyrosine
            C00212  Adenosine
            C00355  3,4-Dihydroxy-L-phenylalanine
            C00575  3',5'-Cyclic AMP
            C00704  O2.-
            C03758  Dopamine
            C04599  1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
            C07593  Rotenone
            C11310  1-Methyl-4-phenylpyridinium
REFERENCE   PMID:17911161
  AUTHORS   Thomas B, Beal MF
  TITLE     Parkinson's disease.
  JOURNAL   Hum Mol Genet 16 Spec No. 2:R183-94 (2007)
            DOI:10.1093/hmg/ddm159
REFERENCE   PMID:12938733
  AUTHORS   Lim KL, Lim TM
  TITLE     Molecular mechanisms of neurodegeneration in Parkinson's disease: clues from Mendelian syndromes.
  JOURNAL   IUBMB Life 55:315-22 (2003)
            DOI:10.1080/1521654031000153030
REFERENCE   PMID:16022590
  AUTHORS   Moore DJ, West AB, Dawson VL, Dawson TM
  TITLE     Molecular pathophysiology of Parkinson's disease.
  JOURNAL   Annu Rev Neurosci 28:57-87 (2005)
            DOI:10.1146/annurev.neuro.28.061604.135718
REFERENCE   PMID:16495942
  AUTHORS   Abou-Sleiman PM, Muqit MM, Wood NW
  TITLE     Expanding insights of mitochondrial dysfunction in Parkinson's disease.
  JOURNAL   Nat Rev Neurosci 7:207-19 (2006)
            DOI:10.1038/nrn1868
REFERENCE   PMID:18426756
  AUTHORS   Mizuno Y, Hattori N, Kubo S, Sato S, Nishioka K, Hatano T, Tomiyama H, Funayama M, Machida Y, Mochizuki H
  TITLE     Progress in the pathogenesis and genetics of Parkinson's disease.
  JOURNAL   Philos Trans R Soc Lond B Biol Sci 363:2215-27 (2008)
            DOI:10.1098/rstb.2008.2273
REFERENCE   PMID:16278972
  AUTHORS   Gandhi S, Wood NW
  TITLE     Molecular pathogenesis of Parkinson's disease.
  JOURNAL   Hum Mol Genet 14 Spec No. 2:2749-2755 (2005)
            DOI:10.1093/hmg/ddi308
REFERENCE   PMID:12461550
  AUTHORS   Lotharius J, Brundin P
  TITLE     Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein.
  JOURNAL   Nat Rev Neurosci 3:932-42 (2002)
            DOI:10.1038/nrn983
REFERENCE   PMID:15767499
  AUTHORS   Eriksen JL, Wszolek Z, Petrucelli L
  TITLE     Molecular pathogenesis of Parkinson disease.
  JOURNAL   Arch Neurol 62:353-7 (2005)
            DOI:10.1001/archneur.62.3.353
REFERENCE   PMID:15054086
  AUTHORS   Sidhu A, Wersinger C, Vernier P
  TITLE     Does alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse?
  JOURNAL   FASEB J 18:637-47 (2004)
            DOI:10.1096/fj.03-1112rev
REFERENCE   PMID:15681812
  AUTHORS   Sidhu A, Wersinger C, Moussa CE, Vernier P
  TITLE     The role of alpha-synuclein in both neuroprotection and neurodegeneration.
  JOURNAL   Ann N Y Acad Sci 1035:250-70 (2004)
            DOI:10.1196/annals.1332.016
REFERENCE   PMID:12971891
  AUTHORS   Dauer W, Przedborski S
  TITLE     Parkinson's disease: mechanisms and models.
  JOURNAL   Neuron 39:889-909 (2003)
            DOI:10.1016/S0896-6273(03)00568-3
REFERENCE   PMID:15525720
  AUTHORS   Feany MB
  TITLE     New genetic insights into Parkinson's disease.
  JOURNAL   N Engl J Med 351:1937-40 (2004)
            DOI:10.1056/NEJMp048263
REFERENCE   PMID:11331916
  AUTHORS   Beal MF
  TITLE     Experimental models of Parkinson's disease.
  JOURNAL   Nat Rev Neurosci 2:325-34 (2001)
            DOI:10.1038/35072550
REFERENCE   PMID:15770999
  AUTHORS   Corti O, Hampe C, Darios F, Ibanez P, Ruberg M, Brice A
  TITLE     Parkinson's disease: from causes to mechanisms.
  JOURNAL   C R Biol 328:131-42 (2005)
            DOI:10.1016/j.crvi.2004.10.009
REFERENCE   PMID:18680555
  AUTHORS   Vila M, Ramonet D, Perier C
  TITLE     Mitochondrial alterations in Parkinson's disease: new clues.
  JOURNAL   J Neurochem 107:317-28 (2008)
            DOI:10.1111/j.1471-4159.2008.05604.x
REFERENCE   PMID:12728264
  AUTHORS   Vila M, Przedborski S
  TITLE     Targeting programmed cell death in neurodegenerative diseases.
  JOURNAL   Nat Rev Neurosci 4:365-75 (2003)
            DOI:10.1038/nrn1100
REFERENCE   PMID:22927178
  AUTHORS   Calabresi P, Di Filippo M, Gallina A, Wang Y, Stankowski JN, Picconi B, Dawson VL, Dawson TM
  TITLE     New synaptic and molecular targets for neuroprotection in Parkinson's disease.
  JOURNAL   Mov Disord 28:51-60 (2013)
            DOI:10.1002/mds.25096
REFERENCE   PMID:21811441
  AUTHORS   Nishi A, Kuroiwa M, Shuto T
  TITLE     Mechanisms for the modulation of dopamine d(1) receptor signaling in striatal neurons.
  JOURNAL   Front Neuroanat 5:43 (2011)
            DOI:10.3389/fnana.2011.00043
REFERENCE   PMID:20236221
  AUTHORS   Hara M, Fukui R, Hieda E, Kuroiwa M, Bateup HS, Kano T, Greengard P, Nishi A
  TITLE     Role of adrenoceptors in the regulation of dopamine/DARPP-32 signaling in neostriatal neurons.
  JOURNAL   J Neurochem 113:1046-59 (2010)
            DOI:10.1111/j.1471-4159.2010.06668.x
KO_PATHWAY  ko05012
///
